Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinhuang Qingfei
- Development stage
- Unknown
- Lead developer
- Hunan Anbang Pharmaceutical
- Administration
- Oral
01
Overview
Yinhuang Qingfei is a traditional Chinese medicine (TCM) herbal combination formula, most commonly available as the "Yin-Huang-Qing-Fei capsule" (YHQFC). It has been widely used in China for decades to treat chronic bronchitis and other respiratory conditions. The formula consists of multiple herbal ingredients and is designed to attenuate inflammation, modulate immune responses, and address pathological changes associated with asthma and chronic bronchitis. Network pharmacology studies suggest that its mechanism involves regulation of inflammatory cytokines such as interleukins (IL-3, IL-4, IL-5, IL-10, IL-13), FCER1G (high affinity immunoglobulin epsilon receptor subunit gamma), CCL11 (eotaxin), and EPX (eosinophil peroxidase). Clinical trials have demonstrated efficacy comparable to antibiotics like amoxicillin-clavulanate in treating chronic simple bronchitis[1][2]. The precise composition may vary by manufacturer but typically includes a blend of herbs with anti-inflammatory and immunomodulatory properties.
- Brand names
- Yinhuang QingfeiYin-Huang-Qing-Fei capsuleYHQFC
- Other names
- Yinhuang Qingfei Jiaonang
02
Targets
FCER1G (Fc epsilon receptor I gamma subunit)IL3 (IL-3)IL-5 (Interleukin 5)IL10 (Interleukin-10)IL-4 (Interleukin 4)CCL11 (C-C motif chemokine ligand 11)EPO (Erythropoietin)IL-13 (Interleukin-13)
Beyond the preview
Go deeper on Yinhuang Qingfei.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yinhuang Qingfei.